Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Nederlands Tijdschrift Voor Geneeskunde|June 6, 2003
[Twenty-five years of cyclosporin use in transplantation medicine]D A Hesselink, P M van Hagen, A H M M Balk, et al.The British Journal of Surgery|May 19, 2017
Systematic review of surgical and medical treatment for tertiary hyperparathyroidismR R Dulfer, G J H Franssen, D A Hesselink, et al.Expert Opinion on Drug Metabolism & Toxicology|March 25, 2016
Pharmacogenetic aspects of the use of tacrolimus in renal transplantation: recent developments and ethnic considerationsJ T Tang, L M Andrews, T van Gelder, et al.European Journal of Clinical Pharmacology|May 14, 2022
Body composition is associated with tacrolimus pharmacokinetics in kidney transplant recipientsM I Francke, W J Visser, D Severs, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|August 6, 2024
The SElf-Care After REnal Transplantation Study: A Retrospective Evaluation of a Home-Monitoring Program Implemented as Standard CareB Hezer, M E J Reinders, M W F van den Hoogen, et al.Transplant Immunology|November 17, 2007
Kinetic analysis reveals potency of CD4+ CD25bright+ regulatory T-cells in kidney transplant patientsJ H L Velthuis, D A Hesselink, T K Hendrikx, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|September 1, 2004
The relative importance of cyclosporine exposure in heart, kidney or liver transplant recipients on maintenance therapyD A Hesselink, T van Dam, H J Metselaar, et al.Clinical and Experimental Immunology|January 11, 2018
Characterization of ectopic lymphoid structures in different types of acute renal allograft rejectionK de Leur, M C Clahsen-van Groningen, T P P van den Bosch, et al.British Journal of Clinical Pharmacology|December 16, 2018
A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipientsL M Andrews, D A Hesselink, R H N van Schaik, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2015
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney TransplantationN Shuker, R Bouamar, R H N van Schaik, et al.Pageof 4